ご使用のウェブブラウザは2021年6月30日をもってReste.comでサポートされなくなります。
お手数ですが、その他のウェブブラウザをインストールしてください。詳しくはこちらをご覧ください。
Peaks | tR (min) | |
---|---|---|
1. | N,N-desmethyl Psilocybin (Norbaeocystin) | 1.710 |
2. | N-desmethyl Psilocybin (Baeocystin) | 2.258 |
3. | 5-hydroxy-N-Methyltryptamine (5-hydroxy NMT) | 2.636 |
4. | Aeruginascin | 2.721 |
5. | Psilocybin | 2.851 |
6. | 5-hydroxy-N,N-Dimethyltryptamine (Bufotenine) | 3.031 |
Column | Force Biphenyl (cat.# 962931E) | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dimensions: | 100 mm x 3.0 mm ID | ||||||||||||||||||||||||||||
Particle Size: | 3 µm | ||||||||||||||||||||||||||||
Pore Size: | 100 Å | ||||||||||||||||||||||||||||
Guard Column: | Force Biphenyl EXP Guard Cartridge 5 mm, 3.0 mm ID (cat.# 962950253) | ||||||||||||||||||||||||||||
Temp.: | 60 °C | ||||||||||||||||||||||||||||
Standard/Sample | |||||||||||||||||||||||||||||
Diluent: | Water | ||||||||||||||||||||||||||||
Conc.: | 50 ppm | ||||||||||||||||||||||||||||
Inj. Vol.: | 1 µL | ||||||||||||||||||||||||||||
Mobile Phase | |||||||||||||||||||||||||||||
A: | Water, 10 mM ammonium formate, 0.1% formic acid | ||||||||||||||||||||||||||||
B: | Methanol, 0.1% formic acid | ||||||||||||||||||||||||||||
|
Detector | UV/Vis @ 222 nm |
---|---|
Flow Cell Size: | 500 nL |
Instrument | Waters ACQUITY UPLC H-Class |
Sample Preparation | Standards were prepared in a 2.0 mL amber, short-cap vial (cat.# 21142) with a 250 µL glass insert (cat.# 24518) and capped with a 9 mm short cap (cat.# 24497). |
Notes | System and column were passivated using LC Passivation Solution (cat.# 32475). The outlined method conditions were used to perform five injections of passivation solution (5 µL) on column, diverting to waste. Five warm-up injections were completed prior to analysis. Storage Conditions: Flush column using acetonitrile with 0.1% formic acid for 5 min. |